Industry Responds to UK Government’s Vision for the Future of Clinical Research

March 25, 2021
Pharmaceutical Technology Editors

ABPI has responded to the publication of the UK government’s plans for the future of clinical research.

In a March 23, 2021 press release, the Association of the British Pharmaceutical Industry (ABPI) has responded to the publication of the UK government’s plans for the future of clinical research.

“We’ve seen the power of clinical research in bringing us the vaccines that are now edging us closer to the end of this pandemic,” said Richard Torbett, CEO of ABPI. “[The government’s] vision reflects the shared priorities we have for the future of clinical research. This welcome framework sets out how we can work together to get clinical research up and running again and build an even stronger research environment in the UK.”

The government’s vision, which was developed in collaboration with the UK’s devolved administrations, lays out plans on the how the country will be able to deliver faster, more efficient, and more innovative research. Built around five key themes, the vision aims to embed clinical research in the national health service, make access and participation in research as easy as possible for patients, put the UK at the forefront of innovation in the field, ensure the most advanced and data-enabled tools are available for use, and create a sustainable and supported research workforce.

Sources: ABPI, UK Gov